Clinical Trial Search

Primary: Number of Participants Reporting Solicited Local or Systemic Adverse Events (AEs) — 3; 4; 3; 5 Participants

Primary: Primary Efficacy Endpoint: The Rate of Device Leak >5 mm at 45-day Post-Implant TEE for the Primary Analysis Subjects — 0 Participants

Primary: Mean Change in Tear Breakup Time From Baseline to Month 1 — 11.7; -0.3 seconds — p=<0.0001

Primary: Prospective-Retrospective Memory Questionnaire (PRMQ; Crawford et al., 2006) — 50.38; 38.5; 47.875; 42.5 score on a scale

Primary: Percentage of Participants Achieving ≥75% Reduction From Baseline in Psoriasis Area and Severity Index (PASI-75) — 18.8; 5.9 percentage of participants — p=0.316

Primary: Change in Acute Effects of Cannabis on Mobility Gait Speed (m/s) — 2.89; 3.11; 2.87; 2.99 m/s — p=0.17

Primary: Mean Change in Weekly Mean Worst Itch Numeric Rating Score (WI-NRS) — -4.0; -3.5 units on a scale

Primary: Changes in fMRI Signal — 0.261; -0.264 Pearson's rho — p=0.023

Primary: Impairment of Insulin Sensitivity — -0.80; 0.55 (mU/L)^-1 min^-1

Primary: Change in Mental Rotation Ability at 8 Weeks — 0.0; -0.6; .82 Amount of Change in Number Correct Items — p==.066

Primary: Percentage of Participants With Client Satisfaction Questionnaire 3-Item (CSQ-3) Scores Above and Below the Scale Midpoint — 34; 35; 0; 1 Participants

Primary: Mean Knowledge of Stress First Aid (SFA) Assessed by Stress First Aid Knowledge, Confidence, and Beliefs - Knowledge Sub-Scale at 4 Months — 4.01 Score on a Scale

Primary: Diabetes Distress at 12 Months — 2.34; 2.03; 2.06 score on a scale — p=.007

Primary: PSA Response Rate — 10; 44 Participants — p=0.0025

Primary: Positive Parenting Practices: EMA Data Positive Parenting Activity Engagement — 3.75; 2.38 Daily number of activities — p=<0.01